Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > GSK > Summary

More on GSK

GlaxoSmithKline plc
(GSK)

38.47USD   Up0.35 (0.92%)   
At 2:30AM IST
 GlaxoSmithKline plc (NYSE:GSK) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 38.47USD
Trade Time:2:30AM IST
Change:Up0.35 (0.92%)
Prev Close:38.12
Open:38.26
Bid:N/A
Ask:N/A
1y Target Est:42.23
Day's Range:37.95 - 38.75
52wk Range:27.15 - 43.47
Volume:3,263,709
Avg Vol (3m):1,788,550
Market Cap:97.52B
P/E (ttm):12.37
EPS (ttm):3.11
Div & Yield:1.86 (4.87%)
Add GSK to Portfolio   Download Data

HEADLINES

 
•Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets - Barrons.com  - Wed 6:50AM
•Bone Up On This Potential Blockbuster - Motley Fool  - Tue 10:28PM
•Europe Launches Probe into Pharma Deals - BusinessWeek  - Tue 9:22PM
•Germany Cancels Swine Flu Vaccines - BusinessWeek  - Tue 9:22PM
•Glaxo considering job cuts at UK research center - AP  - Tue 9:11PM
•Biotech Deal-Making Crosses Borders as Capital Markets Slide - Seeking Alpha  - Tue 3:02PM
•Dynavax starts hepatitis B trial - bizjournals.com  - Tue 6:35AM
•Popular antidepressant interferes with cancer drug - Reuters  - Tue 5:30AM
•Vitaliy Katsenelson Reveals "The Perfect Stock for This Economy" - TechTicker  - Mon, Feb 8
•UPDATE - Roche licenses new flu-fighting technology - Reuters  - Mon, Feb 8
•GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps - Seeking Alpha  - Mon, Feb 8
•How Big Pharma Got in This Fix - Seeking Alpha  - Sun, Feb 7
•Believe In The Market's Healthy Skepticism - Forbes.com  - Sat, Feb 6
•Big Pharma's Shot In The Arm - CNBC  - Sat, Feb 6
•Vaccines Drive Glaxo's Revenues - Zacks.com  - Fri, Feb 5
» More Headlines for GSK...

ANALYST

 
EPS Est (next year) (Dec-09) :3.86
EPS Est (in 2 years) (Dec-10) :3.48
Avg Rec (current)*:3.3
PEG Ratio:2.65
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products.

» Full Company Profile